These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 8004034)
1. Contribution of "in vitro" assays to preclinical and premarketing testing in immunotoxicology. Procházková J Cent Eur J Public Health; 1993 Dec; 1(2):101-5. PubMed ID: 8004034 [TBL] [Abstract][Full Text] [Related]
2. The use of the rat in developmental immunotoxicology studies. Chapin RE Hum Exp Toxicol; 2002; 21(9-10):521-3. PubMed ID: 12458910 [TBL] [Abstract][Full Text] [Related]
3. Present and future of in vitro immunotoxicology in drug development. Galbiati V; Mitjans M; Corsini E J Immunotoxicol; 2010; 7(4):255-67. PubMed ID: 20735150 [TBL] [Abstract][Full Text] [Related]
4. Issues with introducing new immunotoxicology methods into the safety assessment of pharmaceuticals. Dean JH Toxicology; 1997 Apr; 119(1):95-101. PubMed ID: 9129200 [TBL] [Abstract][Full Text] [Related]
6. Principles and practices of integrating genotoxicity evaluation into routine toxicology studies: a pharmaceutical industry perspective. Krishna G; Urda G; Theiss J Environ Mol Mutagen; 1998; 32(2):115-20. PubMed ID: 9776173 [TBL] [Abstract][Full Text] [Related]
7. Immunotoxicant screening and prioritization in the twenty-first century. Luebke R Toxicol Pathol; 2012; 40(2):294-9. PubMed ID: 22105646 [TBL] [Abstract][Full Text] [Related]
8. Risk assessment in immunotoxicology. I. Sensitivity and predictability of immune tests. Luster MI; Portier C; Pait DG; White KL; Gennings C; Munson AE; Rosenthal GJ Fundam Appl Toxicol; 1992 Feb; 18(2):200-10. PubMed ID: 1534777 [TBL] [Abstract][Full Text] [Related]
9. What are the prospects for regulation in immunotoxicology? Hastings KL Toxicol Lett; 1998 Dec; 102-103():267-70. PubMed ID: 10022264 [TBL] [Abstract][Full Text] [Related]
10. In vitro evaluation of drug-induced toxic effects on the immune system as assessed by proliferative assays and cytokine production. Pallardy M; Lebrec H; Blot C; Burleson GR; Bohuon C Eur Cytokine Netw; 1991; 2(3):201-6. PubMed ID: 1893072 [No Abstract] [Full Text] [Related]
11. The mouse as a model for developmental immunotoxicology. Holladay SD; Blaylock BL Hum Exp Toxicol; 2002; 21(9-10):525-31. PubMed ID: 12458911 [TBL] [Abstract][Full Text] [Related]
12. [Toxicology animal studies necessary for clinical research and registration of drugs for human use: conclusions of the International Harmonization Conference (I)]. Rubio Terrés C; Duque I; Tristán C; Galende I Med Clin (Barc); 1993 Nov; 101(18):705-16. PubMed ID: 8114529 [No Abstract] [Full Text] [Related]
13. In vitro and in vivo methods in immunotoxicology. Krakowka S Toxicol Pathol; 1987; 15(3):276-80. PubMed ID: 3685788 [TBL] [Abstract][Full Text] [Related]
14. Position of immunological techniques in screening in clinical toxicology. George S Clin Chem Lab Med; 2004; 42(11):1288-309. PubMed ID: 15576291 [TBL] [Abstract][Full Text] [Related]